257 related articles for article (PubMed ID: 26645460)
1. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
[TBL] [Abstract][Full Text] [Related]
2. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K
Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
[TBL] [Abstract][Full Text] [Related]
3. Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations.
Codenotti S; Mansoury W; Pinardi L; Monti E; Marampon F; Fanzani A
Onco Targets Ther; 2019; 12():5257-5268. PubMed ID: 31308696
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated liposarcoma with lipoma-like well-differentiated liposarcoma: clinicopathological study of 30 cases, with particular attention to the comingling pattern of well- and dedifferentiated components: a proposal for regrouping of the present subclassification of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Iwasa Y; Nakashima Y
Int J Surg Pathol; 2013 Feb; 21(1):15-21. PubMed ID: 22674916
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
6. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.
Avallone G; Roccabianca P; Crippa L; Lepri E; Brunetti B; Bernardini C; Forni M; Olandese A; Sarli G
Vet Pathol; 2016 Jul; 53(4):773-80. PubMed ID: 26993784
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
[TBL] [Abstract][Full Text] [Related]
8. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
9. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
[TBL] [Abstract][Full Text] [Related]
10. Well-differentiated liposarcoma of the retroperitoneum: a clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation.
Elgar F; Goldblum JR
Mod Pathol; 1997 Feb; 10(2):113-20. PubMed ID: 9127316
[TBL] [Abstract][Full Text] [Related]
11. Rare Aggressive Behavior of
Ben Salha I; Zaidi S; Noujaim J; Miah AB; Fisher C; Jones RL; Thway K
Rare Tumors; 2016 Sep; 8(3):6282. PubMed ID: 27746879
[TBL] [Abstract][Full Text] [Related]
12. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.
Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL
Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480
[TBL] [Abstract][Full Text] [Related]
13. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases.
Kryvenko ON; Rosenberg AE; Jorda M; Epstein JI
Am J Surg Pathol; 2015 Sep; 39(9):1219-25. PubMed ID: 25828386
[TBL] [Abstract][Full Text] [Related]
15. Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives.
Nishio J; Nakayama S; Nabeshima K; Yamamoto T
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362013
[TBL] [Abstract][Full Text] [Related]
16. Well-Differentiated Liposarcoma With Hibernoma-Like Morphology.
Hallin M; Schneider N; Thway K
Int J Surg Pathol; 2016 Oct; 24(7):620-2. PubMed ID: 27272683
[TBL] [Abstract][Full Text] [Related]
17. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
Ng W; Messiou C; Smith M; Thway K
Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
[TBL] [Abstract][Full Text] [Related]
18. Liposarcoma: new entities and evolving concepts.
Dei Tos AP
Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.
Thway K; Wang J; Swansbury J; Min T; Fisher C
Sarcoma; 2015; 2015():812089. PubMed ID: 25810689
[TBL] [Abstract][Full Text] [Related]
20. p16 Immunohistochemistry is Less Useful Than MDM2 and CDK4 to Distinguish Dedifferentiated Liposarcomas From Other Retroperitoneal Mimics.
Kang Y; Horvai AE
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):58-63. PubMed ID: 26509911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
